Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A05138 | 33359400 | Mol Metab | Nuclear hormone and peptide hormone therapeutics for NAFLD and NASH. | 2020 | Details |
| A05139 | 33358864 | Biochim Biophys Acta Gen Subj | GDF15 as a central mediator for integrated stress response and a promising therapeutic molecule for metabolic disorders and NASH. | 2020 | Details |
| A05140 | 33358861 | Exp Cell Res | Src-mediated Tyr353 phosphorylation of IP3R1 promotes its stability and causes apoptosis in palmitic acid-treated hepatocytes. | 2021 | Details |
| A05141 | 33358553 | Ultrasound Med Biol | Use of a convolutional neural network and quantitative ultrasound for diagnosis of fatty liver. | 2020 | Details |
| A05143 | 33358052 | Ultrasound Med Biol | Accuracy of Controlled Attenuation Parameter and Liver Stiffness Measurement in Patients with Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A05144 | 33357707 | Poult Sci | Based on network pharmacology method to discovered the targets and therapeutic mechanism of Paederia scandens against nonalcoholic fatty liver disease in chicken. | 2020 | Details |
| A05145 | 33356548 | Pharmacogenomics | Clinical and genetic risk factors for the prediction of hepatotoxicity induced by a docetaxel, epirubicin and cyclophosphamide regimen in breast cancer patients. | 2020 | Details |
| A05146 | 33355256 | Diabetes Care | Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening. | 2020 | Details |
| A05147 | 33354924 | Basic Clin Pharmacol Toxicol | The effect of acetylsalicylic acid and pentoxifylline in guinea pigs with non-alcoholic steatohepatitis. | 2021 | Details |
| A05148 | 33354866 | Liver Int | Glycogenosis is common in nonalcoholic fatty liver disease and is independently associated with ballooning, but lower steatosis and lower fibrosis. | 2021 | Details |
| A05149 | 33354557 | Can J Gastroenterol Hepatol | Association and Prediction of Subclinical Atherosclerosis by Nonalcoholic Fatty Liver Disease in Asymptomatic Patients. | 2020 | Details |
| A05150 | 33353230 | Nutrients | Effects of Caffeine and Chlorogenic Acid on Nonalcoholic Steatohepatitis in Mice Induced by Choline-Deficient, L-Amino Acid-Defined, High-Fat Diet. | 2020 | Details |
| A05151 | 33353156 | Int J Mol Sci | Cell Death in Liver Diseases: A Review. | 2020 | Details |
| A05152 | 33352841 | Biomedicines | HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD). | 2020 | Details |
| A05153 | 33352578 | Obes Facts | Hepatic Steatosis Is Associated with Elevated Serum Iron in Patients with Obesity and Improves after Laparoscopic Sleeve Gastrectomy. | 2020 | Details |
| A05154 | 33352441 | Int Immunopharmacol | Cordycepin attenuates high-fat diet-induced non-alcoholic fatty liver disease via down-regulation of lipid metabolism and inflammatory responses. | 2020 | Details |
| A05155 | 33352229 | Pharmacol Res | Cryptotanshinone specifically suppresses NLRP3 inflammasome activation and protects against inflammasome-mediated diseases. | 2020 | Details |
| A05156 | 33352183 | Eur J Pharmacol | The effects of glucagon-like peptide-1 receptor agonists on glycemic control and anthropometric profiles among diabetic patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. | 2020 | Details |
| A05157 | 33350984 | JCI Insight | Echinatin effectively protects against NLRP3 inflammasome-driven diseases by targeting HSP90. | 2021 | Details |
| A05158 | 33350463 | Eur J Clin Invest | Deciphering the role of epigenetic modifications in fatty liver disease: A systematic review. | 2021 | Details |
| A05159 | 33350036 | Hepatol Res | A novel rapid immunoassay of serum type IV collagen 7S for the diagnosis of fibrosis stage of nonalcoholic fatty liver diseases. | 2021 | Details |
| A05160 | 33349658 | Nat Rev Gastroenterol Hepatol | Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. | 2020 | Details |
| A05161 | 33348908 | Int J Mol Sci | Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research. | 2020 | Details |
| A05162 | 33348700 | Nutrients | Nutritional Approaches for the Management of Nonalcoholic Fatty Liver Disease: An Evidence-Based Review. | 2020 | Details |
| A05163 | 33348647 | Children (Basel) | Antihistamines Increase Body Mass Index Percentiles and Z-Scores in Hispanic Children. | 2020 | Details |
| A05164 | 33348109 | Nutrition | Development and course of diabetes according to genetic factors and diabetes treatment among patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A05165 | 33348067 | Mol Metab | Function of the endolysosomal network in cholesterol homeostasis and metabolic-associated fatty liver disease (MAFLD). | 2021 | Details |
| A05166 | 33348045 | Clin Gastroenterol Hepatol | Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study. | 2020 | Details |
| A05167 | 33347986 | Free Radic Biol Med | STING-dependent induction of lipid peroxidation mediates intestinal ischemia-reperfusion injury. | 2020 | Details |
| A05169 | 33347879 | Gastroenterology | Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease. | 2021 | Details |
| A05172 | 33346905 | Protein Cell | The role of the gut microbiome and its metabolites in metabolic diseases. | 2020 | Details |
| A05173 | 33346578 | J Pediatr Gastroenterol Nutr | Evaluation of Nonalcoholic Fatty Liver Disease in Pediatric Patients With Inflammatory Bowel Disease. | 2021 | Details |
| A05174 | 33346572 | J Pediatr Gastroenterol Nutr | Incidence of Depression and Anxiety in a Cohort of Adolescents With Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A05175 | 33346465 | Ter Arkh | [Non-alcoholic fatty liver disease and type 2 diabetes mellitus: issues of the liver fibrosis diagnostics]. | 2020 | Details |
| A05176 | 33346459 | Ter Arkh | [Clinical features of the comorbid course of non-alcoholic fatty liver disease and gallstone disease]. | 2020 | Details |
| A05177 | 33346069 | Mol Metab | Metabolic drivers of non-alcoholic fatty liver disease. | 2020 | Details |
| A05178 | 33346004 | Gastroenterology | Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production. | 2020 | Details |
| A05180 | 33345314 | J Cell Physiol | Ghrelin ameliorates nonalcoholic steatohepatitis induced by chronic low-grade inflammation via blockade of Kupffer cell M1 polarization. | 2020 | Details |
| A05181 | 33345307 | Hepatology | Liver Stiffness by Transient Elastography to Detect Porto-Sinusoidal Vascular Liver Disease With Portal Hypertension. | 2021 | Details |
| A05182 | 33344496 | Front Nutr | Abdominal Fat and Metabolic Health Markers but Not PNPLA3 Genotype Predicts Liver Fat Accumulation in Response to Excess Intake of Energy and Saturated Fat in Healthy Individuals. | 2020 | Details |
| A05183 | 33344451 | Front Cell Dev Biol | MicroRNA-20a-5p Ameliorates Non-alcoholic Fatty Liver Disease via Inhibiting the Expression of CD36. | 2020 | Details |
| A05184 | 33343673 | Evid Based Complement Alternat Med | Investigation of the Synergistic Effect of Brown Sugar, Longan, Ginger, and Jujube (Brown Sugar Longan Ginger Tea) on Antioxidation and Anti-Inflammation in In Vitro Models. | 2020 | Details |
| A05185 | 33343508 | Front Endocrinol (Lausanne) | ChREBP-Mediated Regulation of Lipid Metabolism: Involvement of the Gut Microbiota, Liver, and Adipose Tissue. | 2020 | Details |
| A05186 | 33343375 | Front Pharmacol | Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments. | 2020 | Details |
| A05187 | 33343352 | Front Pharmacol | Hepatoprotective Effect and Molecular Mechanisms of Hengshun Aromatic Vinegar on Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A05188 | 33342543 | J Hepatol | Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis. | 2020 | Details |
| A05189 | 33341736 | Biomaterials | Quantification of non-alcoholic fatty liver disease progression in 3D liver microtissues using impedance spectroscopy. | 2020 | Details |
| A05190 | 33341674 | Biochem Biophys Res Commun | Hepatocyte-specific TAZ deletion downregulates p62/ Sqstm1 expression in nonalcoholic steatohepatitis. | 2020 | Details |
| A05191 | 33341312 | Clin Nutr | A randomized controlled clinical trial comparing calcitriol versus cholecalciferol supplementation to reduce insulin resistance in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A05192 | 33341045 | Biomed Pharmacother | β-patchoulene improves lipid metabolism to alleviate non-alcoholic fatty liver disease via activating AMPK signaling pathway. | 2020 | Details |
| A05193 | 33341026 | Phytomedicine | Δ9-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in mice. | 2020 | Details |
| A05194 | 33340925 | Thromb Res | Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease. | 2020 | Details |
| A05195 | 33340780 | Clin Gastroenterol Hepatol | Direct Comparison of US and MR Elastography for Staging Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05203 | 33340539 | Anal Biochem | Measuring acetyl-CoA and acetylated histone turnover in vivo: Effect of a high fat diet. | 2020 | Details |
| A05204 | 33340186 | J Intern Med | Discrepancies between actual weight, weight perception and weight loss intention amongst persons with NAFLD. | 2020 | Details |
| A05207 | 33339155 | Antioxidants (Basel) | N-Acetyl Cysteine Targets Hepatic Lipid Accumulation to Curb Oxidative Stress and Inflammation in NAFLD: A Comprehensive Analysis of the Literature. | 2020 | Details |
| A05208 | 33338730 | Ultrasonics | Utility of quantitative ultrasound in community screening for hepatic steatosis. | 2020 | Details |
| A05210 | 33337654 | Cardiol Rev | Part 1: Disease of the Heart and Liver: A Relationship That Cuts Both Ways. | 2022 | Details |
| A05211 | 33337653 | Cardiol Rev | Part 2: Disease of the Heart and Liver: A Relationship That Cuts Both Ways. | 2020 | Details |
| A05212 | 33337101 | Compr Rev Food Sci Food Saf | Phytosterols and their derivatives: Potential health-promoting uses against lipid metabolism and associated diseases, mechanism, and safety issues. | 2020 | Details |
| A05213 | 33336648 | Diabetes Metab Syndr | Nonalcoholic fatty liver disease should be considered for treatment allocation in standard management algorithms for type 2 diabetes. | 2020 | Details |
| A05214 | 33336323 | Patient | Development of a Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis (NASH-CHECK): Results of a Qualitative Study. | 2020 | Details |
| A05215 | 33336025 | Open Med (Wars) | Effect of glucagon-like peptide-1 receptor agonists on adipokine level of nonalcoholic fatty liver disease in rats fed high-fat diet. | 2020 | Details |
| A05216 | 33335561 | Therap Adv Gastroenterol | The efficacy of vitamin E in reducing non-alcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression. | 2020 | Details |
| A05217 | 33334704 | Dig Liver Dis | Validation of fatty liver disease scoring systems for ultrasound diagnosed non-alcoholic fatty liver disease in adolescents. | 2020 | Details |
| A05218 | 33334622 | Arch Med Res | Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05219 | 33334267 | Int J STD AIDS | Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive people. | 2020 | Details |
| A05220 | 33334062 | Nanomaterials (Basel) | Direct and Label-Free Monitoring of Albumin in 2D Fatty Liver Disease Model Using Plasmonic Nanogratings. | 2020 | Details |
| A05221 | 33334026 | Int J Mol Sci | Pluripotent Stem Cell-Derived Hepatocytes Phenotypic Screening Reveals Small Molecules Targeting the CDK2/4-C/EBPα/DGAT2 Pathway Preventing ER-Stress Induced Lipid Accumulation. | 2020 | Details |
| A05222 | 33333850 | J Clin Med | The Vicious Circle of Hepatic Glucagon Resistance in Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A05223 | 33333240 | Respir Physiol Neurobiol | Functional foods from the tropics to relieve chronic normobaric hypoxia. | 2020 | Details |
| A05224 | 33333172 | Biochimie | Beneficial and deleterious effects of sitagliptin on a methionine/choline-deficient diet-induced steatohepatitis in rats. | 2020 | Details |
| A05225 | 33333040 | Clin Chim Acta | Development and validation of a noninvasive clinical scoring system to predict significant fibrosis in patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A05226 | 33332766 | Immun Inflamm Dis | Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease. | 2020 | Details |
| A05227 | 33331485 | Arq Gastroenterol | GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN GASTROINTESTINAL AND LIVER DISEASES: PROCEEDINGS OF A JOINT MEETING OF THE BRAZILIAN SOCIETY OF HEPATOLOGY (SBH), BRAZILIAN NUCLEUS FOR THE STUDY OF HELICOBACTER PYLORI AND MICROBIOTA (NBEHPM), AND BRAZILIAN FEDERATION OF GASTROENTEROLOGY (FBG). | 2021 | Details |
| A05228 | 33331479 | Arq Gastroenterol | PERIPHERAL BLOOD ENDOTOXIN LEVELS ARE NOT ASSOCIATED WITH SMALL INTESTINAL BACTERIAL OVERGROWTH IN NONALCOHOLIC FATTY LIVER DISEASE WITHOUT CIRRHOSIS. | 2021 | Details |
| A05229 | 33330594 | Front Nutr | Association Between Dietary Fiber Intake and Non-alcoholic Fatty Liver Disease in Adults. | 2020 | Details |
| A05230 | 33330497 | Front Cell Dev Biol | Liraglutide Alleviates Hepatic Steatosis by Activating the TFEB-Regulated Autophagy-Lysosomal Pathway. | 2020 | Details |
| A05231 | 33330100 | Front Oncol | Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease. | 2020 | Details |
| A05232 | 33329401 | Front Endocrinol (Lausanne) | C-Peptide: A Mediator of the Association Between Serum Uric Acid to Creatinine Ratio and Non-Alcoholic Fatty Liver Disease in a Chinese Population With Normal Serum Uric Acid Levels. | 2020 | Details |
| A05233 | 33329394 | Front Endocrinol (Lausanne) | Aerobic Exercise Training Exerts Beneficial Effects Upon Oxidative Metabolism and Non-Enzymatic Antioxidant Defense in the Liver of Leptin Deficiency Mice. | 2020 | Details |
| A05234 | 33328987 | Front Pharmacol | Da-Chai-Hu Decoction Ameliorates High Fat Diet-Induced Nonalcoholic Fatty Liver Disease Through Remodeling the Gut Microbiota and Modulating the Serum Metabolism. | 2020 | Details |
| A05235 | 33328983 | Front Pharmacol | Activation of the AMPK-SIRT1 pathway contributes to protective effects of Salvianolic acid A against lipotoxicity in hepatocytes and NAFLD in mice. | 2020 | Details |
| A05237 | 33328206 | Diabetes | Defective FXR-SHP Regulation in Obesity Aberrantly Increases miR-802 Expression, Promoting Insulin Resistance and Fatty Liver. | 2020 | Details |
| A05239 | 33327816 | J Int Med Res | Using intestinal flora to distinguish non-alcoholic steatohepatitis from non-alcoholic fatty liver. | 2020 | Details |
| A05240 | 33327438 | Int J Mol Sci | Natural Product Heme Oxygenase Inducers as Treatment for Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05241 | 33327335 | Medicine (Baltimore) | Comparison of noninvasive scoring systems for the prediction of nonalcoholic fatty liver disease in metabolic syndrome patients. | 2020 | Details |
| A05242 | 33327291 | Medicine (Baltimore) | Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain. | 2020 | Details |
| A05243 | 33327227 | Medicine (Baltimore) | Study on the new strategy and key techniques for accurate prevention and treatment of nonalcoholic steatohepatitis based on intestinal target bacteria. | 2020 | Details |
| A05244 | 33326684 | IUBMB Life | Combination of metformin and chlorogenic acid attenuates hepatic steatosis and inflammation in high-fat diet fed mice. | 2020 | Details |
| A05245 | 33326461 | PLoS One | The pharmacodynamic and differential gene expression analysis of PPAR α/δ agonist GFT505 in CDAHFD-induced NASH model. | 2020 | Details |
| A05246 | 33325949 | Food Funct | Taxifolin ameliorate high-fat-diet feeding plus acute ethanol binge-induced steatohepatitis through inhibiting inflammatory caspase-1-dependent pyroptosis. | 2020 | Details |
| A05247 | 33325808 | Am J Physiol Gastrointest Liver Physiol | Hepatocyte-specific expression of human carboxylesterase 2 attenuates nonalcoholic steatohepatitis in mice. | 2020 | Details |
| A05248 | 33324350 | Front Endocrinol (Lausanne) | Integrated Multichip Analysis Identifies Potential Key Genes in the Pathogenesis of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A05249 | 33324348 | Front Endocrinol (Lausanne) | Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides. | 2020 | Details |
| A05250 | 33324345 | Front Endocrinol (Lausanne) | Repression of MicroRNA-124-3p Alleviates High-Fat Diet-Induced Hepatosteatosis by Targeting Pref-1. | 2020 | Details |
| A05251 | 33323806 | Chin Med J (Engl) | MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy. | 2020 | Details |
| A05252 | 33323025 | AIDS Res Hum Retroviruses | Pro-Inflammatory Interleukin-18 is Associated with Hepatic Steatosis and Elevated Liver Enzymes in People with HIV Monoinfection. | 2021 | Details |
| A05253 | 33322323 | Animals (Basel) | GC-TOF-MS-Based Metabolomics Analyses of Liver and Intestinal Contents in the Overfed vs. Normally-Fed Geese. | 2020 | Details |
| A05254 | 33321470 | Nucl Med Biol | Radiolabelling and positron emission tomography imaging of a high-affinity peptide binder to collagen type 1. | 2020 | Details |